Jin Litai: the prices of various types of cathodic electrophoretic paint products rise by 10% - 20%

Chassis Supply Chain's "iPhone Moment": China's Tier 1 Shift as LeeKr Emerges

Over the past decade, China's electric vehicle (EV) industry has evolved from a niche experiment into a leading force in the global automotive landscape. In the first ten months of 2025, China exported over 2 million EVs, nearly double the year-earlier figure. From European city streets to Southeast Asian highways and Latin American urban centers, Chinese EVs have emerged as one of the most prominent symbols of a new era of “Made in China.”

Hypershell (极壳科技) Secures $50 Million Series B+ Funding Co-Led by Ant Group (蚂蚁集团) and Meituan Dragonball Capital (美团龙珠), Accelerating Global Expansion of Consumer-Grade Exoskeletons

Consumer-grade exoskeleton startup Hypershell (极壳科技) announced the completion of its $50 million Series B+ financing round co-led by Ant Group (蚂蚁集团) and Meituan DragonBall (美团龙珠), bringing its total Series B series funding to $120 million to accelerate its global leadership in human-augmentation robotics.

Doubao starts charging, Musk's xAI seeks change, the large model track welcomes a new turning point

The new journey of large models has already begun, moving from a tech carnival to value realization, and from野蛮生长 to rational prosperity. This is the inevitable choice of the industry, and even more so, the development trend of the times.

Unpacking China | Key Chinese Firms to Watch This Week （10/05/2026-16/05/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM

There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?